Medpace (MEDP) Exec VP Brad Hansman reports stock, option and RSU holdings
Rhea-AI Filing Summary
Medpace Holdings, Inc. executive Brad W. Hansman, Exec. VP, Operations, filed an initial ownership report showing his equity position in the company. He directly holds 697 shares of common stock, reflecting his current direct stake.
He also holds an employee stock option for 10,000 shares of Medpace common stock at an exercise price of $410.54 per share, expiring on April 24, 2033, which vests in full on April 24, 2031, subject to continued employment. In addition, he has restricted stock units covering 5,000 shares that vest in full on August 5, 2029 and 500 shares that vest in full on April 24, 2031, each unit representing a contingent right to receive one share of MEDP common stock.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Restricted Stock Unit | -- | -- | -- |
| holding | Restricted Stock Unit | -- | -- | -- |
| holding | Employee Stock Option (Right to Buy) | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (4)
- F1. The restricted stock units vest in full on August 5, 2029, subject to the Reporting Person's continued employment with the Issuer or one of its subsidiaries.
- F2. Each restricted stock unit represents a contingent right to receive one share of MEDP common stock.
- F3. The restricted stock units vest in full on April 24, 2031, subject to the Reporting Person's continued employment with the Issuer or one of its subsidiaries.
- F4. The option vests in full on April 24, 2031, subject to the Reporting Person's continued employment with the Issuer or one of its subsidiaries.
Key Figures
Key Terms
Restricted Stock Unit financial
Employee Stock Option (Right to Buy) financial
vest in full financial
AI-generated analysis. How Rhea-AI works. Not financial advice.